Literature DB >> 16639148

The diagnosis and management of benzodiazepine dependence.

Heather Ashton1.   

Abstract

PURPOSE OF REVIEW: Despite repeated recommendations to limit benzodiazepines to short-term use (2-4 weeks), doctors worldwide are still prescribing them for months or years. This over-prescribing has resulted in large populations of long-term users who have become dependent on benzodiazepines and has also led to leakage of benzodiazepines into the illicit drug market. This review outlines the risks of long-term benzodiazepine use, gives guidelines on the management of benzodiazepine withdrawal and suggests ways in which dependence can be prevented. RECENT
FINDINGS: Recent literature shows that benzodiazepines have all the characteristics of drugs of dependence and that they are inappropriately prescribed for many patients, including those with physical and psychiatric problems, elderly residents of care homes and those with comorbid alcohol and substance abuse. Many trials have investigated methods of benzodiazepine withdrawal, of which the keystones are gradual dosage tapering and psychological support when necessary. Several studies have shown that mental and physical health and cognitive performance improve after withdrawal, especially in elderly patients taking benzodiazepine hypnotics, who comprise a large proportion of the dependent population.
SUMMARY: Benzodiazepine dependence could be prevented by adherence to recommendations for short-term prescribing (2-4 weeks only when possible). Withdrawal of benzodiazepines from dependent patients is feasible and need not be traumatic if judiciously, and often individually, managed.

Entities:  

Year:  2005        PMID: 16639148     DOI: 10.1097/01.yco.0000165594.60434.84

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  87 in total

1.  Neurotoxins from snake venoms and α-conotoxin ImI inhibit functionally active ionotropic γ-aminobutyric acid (GABA) receptors.

Authors:  Denis S Kudryavtsev; Irina V Shelukhina; Lina V Son; Lucy O Ojomoko; Elena V Kryukova; Ekaterina N Lyukmanova; Maxim N Zhmak; Dmitry A Dolgikh; Igor A Ivanov; Igor E Kasheverov; Vladislav G Starkov; Joachim Ramerstorfer; Werner Sieghart; Victor I Tsetlin; Yuri N Utkin
Journal:  J Biol Chem       Date:  2015-07-28       Impact factor: 5.157

Review 2.  Prevention of Trauma and Stressor-Related Disorders: A Review.

Authors:  Jonathon R Howlett; Murray B Stein
Journal:  Neuropsychopharmacology       Date:  2015-08-28       Impact factor: 7.853

3.  Use of benzodiazepines and z-drugs not compliant with guidelines and associated factors: a population-based study.

Authors:  Arnaud Panes; Antoine Pariente; Anne Bénard-Laribière; Régis Lassalle; Caroline Dureau-Pournin; Simon Lorrain; Marie Tournier; Annie Fourrier-Réglat
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-12-11       Impact factor: 5.270

4.  Measuring psychotropic drug exposures in register-based studies--validity of a dosage assumption of one unit per day in older Finns.

Authors:  Maria Rikala; Sirpa Hartikainen; Leena K Saastamoinen; Maarit Jaana Korhonen
Journal:  Int J Methods Psychiatr Res       Date:  2013-05-16       Impact factor: 4.035

5.  The epidemiology of benzodiazepine misuse: A systematic review.

Authors:  Victoria R Votaw; Rachel Geyer; Maya M Rieselbach; R Kathryn McHugh
Journal:  Drug Alcohol Depend       Date:  2019-05-07       Impact factor: 4.492

6.  Benzodiazepine dependence among multidrug users in the club scene.

Authors:  Steven P Kurtz; Hilary L Surratt; Maria A Levi-Minzi; Angela Mooss
Journal:  Drug Alcohol Depend       Date:  2011-06-25       Impact factor: 4.492

Review 7.  Effects of benzodiazepines administration on identification of facial expressions of emotion: a meta-analysis.

Authors:  Helena Garcez; Carina Fernandes; Fernando Barbosa; Mariana R Pereira; Celeste Silveira; João Marques-Teixeira; Ana R Gonçalves
Journal:  Psychopharmacology (Berl)       Date:  2019-11-18       Impact factor: 4.530

8.  Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study.

Authors:  Kuo-Hsuan Chung; Chung-Yi Li; Shu-Yu Kuo; Trevor Sithole; Wen-Wei Liu; Min-Huey Chung
Journal:  J Clin Sleep Med       Date:  2015-04-15       Impact factor: 4.062

9.  Level and factors of benzodiazepines misuse in Albania.

Authors:  Suela Kellici; Ela Hoti; Genc Burazeri
Journal:  Int J Clin Pharm       Date:  2013-02-20

Review 10.  Withdrawing Benzodiazepines in Patients With Anxiety Disorders.

Authors:  Malcolm Lader; Andri Kyriacou
Journal:  Curr Psychiatry Rep       Date:  2016-01       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.